North America Medical Gloves Market exceeded USD 6.5 billion in 2021 and is projected to showcase around 19% growth rate from 2022 to 2028.
Several infectious disease outbreaks have occurred over the last decade, including Zika, Ebola, and the ongoing COVID-19 pandemic. In response to the rising prevalence of such communicable diseases, the healthcare industry has prioritized safety needs of medical staff by emphasizing the use of personal protective equipment (PPE).
Get more details on this report - Request Free Sample PDF
Since medical gloves safeguard both patients and caregivers by avoiding possible transmission of contagious diseases, they are crucial part of the PPE used in the healthcare ecosystem. The growing threat of infectious and chronic illnesses, rising need for surgeries, and improved healthcare systems are likely to boost the market revenue.
Impact of COVID-19 outbreak on North America medical gloves market outlook
As the global coronavirus outbreak struck the world in late 2019, the World Health Organization (WHO) recommended the use of medical gloves for all healthcare operations. There include surgical interventions, examinations, routine check-ups, and testing. This resulted in a significant demand for medical gloves in 2020 to protect patients and healthcare professionals against disease cross-contamination.
The examination application segment in the North America medical gloves market will register a CAGR of 18% during the forecast timeline. Examination gloves shield the skin from blood-borne diseases, making them a prerequisite in medical and healthcare settings. The recent COVID-19 outbreak emerged as an unprecedented public health hazard, which positively impacted PPE sales. According to UNICEF, the demand for PPE supplies has increased tremendously since 2020. Regarded as an essential component of PPE, examination medical glove production rose to a considerable extent during the pandemic time.
North America medical disposable gloves market share is expected to grow significantly through 2028. There is an increased risk of transmission of infectious pathogens in clinical settings. Also, the awareness of infection control methods and products is growing amongst medical professionals and patients.
Since these gloves can be used one-time and disposed of easily, it minimizes the risk of potential infection by blood-borne pathogens and harmful chemicals. Increasing awareness pertaining to the safety and hygiene to safeguard healthcare professionals and patients against infections has led to surging demand for disposable gloves. High quality products are witnessing a spike in use across hospitals, veterinary clinics, and dental settings.
The increasing inflow of patients undergoing surgeries in hospitals is positively impacting the product uptake. According to the Canadian Medical Association Journal (CMAJ), the number of global annual cataract surgeries crossed 9.5 million, with Ontario accounting for a significant percentage of them.
Reimbursement policies pertaining to surgical procedures in hospitals is one of the crucial factors encouraging patients to undergo surgeries in hospitals. Furthermore, the novel coronavirus pandemic boosted the production and sales of medical gloves for use in hospitals, owing to rapidly growing number of patients to be examined and treated.
Prominent participants operating across the North America medical gloves market include Supermax Corporation Berhad, Top Glove Corporation Berhad, Medline Industries Inc., Ansell Limited, Cardinal Health Inc., and Robinson Healthcare. To grab a larger market share, these companies have been focusing on business strategies such as partnerships, new product launch, collaborations, mergers acquisitions, etc.
With several domestic start-ups appearing in the U.S., the legacy brands are likely to focus on quality improvement and sustainability concerns. Top Glove, a leading Malaysia-based glove manufacturer, recently achieved recognition for its outstanding commitment to sustainable practices from multiple indices. Numerous companies will reap the benefits of the national Department of Health and Human Services (HHS)’s funds worth over USD 572 million, supporting U.S. glove manufacturing.